Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Heart Failure VI: Adjunct Therapies01:22

Heart Failure VI: Adjunct Therapies

133
Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
133
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

160
Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
160
Cardiac Catheterization I: Pre-Procedure Overview01:28

Cardiac Catheterization I: Pre-Procedure Overview

643
Cardiac catheterization is an invasive diagnostic technique used to identify and evaluate structural and functional diseases of the heart and major blood vessels. This technique diagnoses congenital heart disease, coronary artery disease, valvular heart disease, and coronary spasms and assesses ventricular function. It helps guide treatment decisions, including the need for revascularization procedures like percutaneous coronary intervention (PCI) or coronary artery bypass grafting (CABG) and...
643
Cardiac Catheterization III: Left Heart Catheterization01:24

Cardiac Catheterization III: Left Heart Catheterization

380
Left heart catheterization is an invasive diagnostic procedure used to evaluate the function and structure of the left side of the heart. It is generally performed to diagnose and treat cardiovascular conditions such as valve abnormalities, coronary artery disease, and congenital heart defects.Diagnostic and therapeutic purposesLeft heart catheterization serves various diagnostic and therapeutic purposes, including:Assessing coronary artery bypass grafts.Evaluating coronary artery disease in...
380
Cardiac Catheterization II: Right Heart Catheterization01:21

Cardiac Catheterization II: Right Heart Catheterization

456
Right Heart Catheterization: An OverviewRight heart catheterization is an invasive diagnostic procedure that measures right-sided cardiac and pulmonary artery pressures, calculates cardiac output, and identifies intracardiac shunts. It provides detailed hemodynamic data essential for diagnosing and managing various cardiovascular conditions, such as pulmonary hypertension.Access SitesCommon access sites for right heart catheterization include the internal jugular vein in the neck region, the...
456
Cardiac Catheterization IV: Nursing Management01:26

Cardiac Catheterization IV: Nursing Management

448
Nursing responsibilities before cardiac catheterization include:Assess for allergies and establish baseline health status.Before cardiac catheterization, assess the patient for allergies to contrast dye. Perform a comprehensive baseline assessment, including vital signs, heart and breath sounds, and a neurovascular assessment of the extremities, noting distal pulses, skin color, and temperature. Instruct the patient to fast for 8-12 hours before the procedure. Evaluate baseline laboratory...
448

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Correction: A novel thermochromic myocardial phantom for radiofrequency ablation and cryoablation.

Scientific reports·2026
Same author

Superior venous use of bridge balloon for percutaneous lead extraction in a patient with an interrupted inferior vena cava: a case report.

European heart journal. Case reports·2026
Same author

Cardiac sarcoidosis imaging features and latest advances in the management of arrhythmias: a case report.

European heart journal. Case reports·2026
Same author

Temporary PFO Closure to Mitigate Embolic Risk During Percutaneous Debulking of Large Tricuspid Valve Vegetations.

JACC. Case reports·2026
Same author

Safety Outcomes of Hybrid Open Chest Transvenous Lead Extraction: A Multicenter Experience.

Pacing and clinical electrophysiology : PACE·2025
Same author

A novel thermochromic myocardial phantom for radiofrequency ablation and cryoablation.

Scientific reports·2025

Related Experiment Video

Updated: Dec 2, 2025

A New Single Chamber Implantable Defibrillator with Atrial Sensing: A Practical Demonstration of Sensing and Ease of Implantation
16:40

A New Single Chamber Implantable Defibrillator with Atrial Sensing: A Practical Demonstration of Sensing and Ease of Implantation

Published on: February 28, 2012

26.6K

New frontiers in cardiac devices.

Adam Sc Dennis1, Jonathan M Behar2

  • 1Department of Cardiology, St. Bartholomew's Hospital, Barts Health NHS Trust, London, UK.

British Journal of Hospital Medicine (London, England : 2005)
|November 2, 2020
PubMed
Summary

This review covers advances in cardiac device management, including pacing for bradycardia and arrhythmia therapies. It highlights current guidelines, complications, and future innovations like leadless pacemakers and portable diagnostics.

Keywords:
CardiologyGuidelinesPacingReview

More Related Videos

Bidirectional Electrical and Optoelectronic Interfaces in Healthy and Ischemic Ex Vivo Rat Hearts
08:33

Bidirectional Electrical and Optoelectronic Interfaces in Healthy and Ischemic Ex Vivo Rat Hearts

Published on: July 18, 2025

617
Use of a Percutaneous Ventricular Assist Device/Left Atrium to Femoral Artery Bypass System for Cardiogenic Shock
07:39

Use of a Percutaneous Ventricular Assist Device/Left Atrium to Femoral Artery Bypass System for Cardiogenic Shock

Published on: August 16, 2021

3.9K

Related Experiment Videos

Last Updated: Dec 2, 2025

A New Single Chamber Implantable Defibrillator with Atrial Sensing: A Practical Demonstration of Sensing and Ease of Implantation
16:40

A New Single Chamber Implantable Defibrillator with Atrial Sensing: A Practical Demonstration of Sensing and Ease of Implantation

Published on: February 28, 2012

26.6K
Bidirectional Electrical and Optoelectronic Interfaces in Healthy and Ischemic Ex Vivo Rat Hearts
08:33

Bidirectional Electrical and Optoelectronic Interfaces in Healthy and Ischemic Ex Vivo Rat Hearts

Published on: July 18, 2025

617
Use of a Percutaneous Ventricular Assist Device/Left Atrium to Femoral Artery Bypass System for Cardiogenic Shock
07:39

Use of a Percutaneous Ventricular Assist Device/Left Atrium to Femoral Artery Bypass System for Cardiogenic Shock

Published on: August 16, 2021

3.9K

Area of Science:

  • Cardiology
  • Biomedical Engineering

Background:

  • The field of implantable cardiac devices has advanced significantly over the last 70 years.
  • These devices encompass diagnostic tools and electrical therapies for various cardiac conditions.

Purpose of the Study:

  • To provide an overview of current cardiac device management.
  • To discuss complications associated with cardiac devices.
  • To explore future areas for development in cardiac device technology.

Main Methods:

  • Review of current international guidelines on heart rhythm diagnostics, pacing, cardiac resynchronisation, and implantable cardioverter defibrillators.
  • Discussion of common complications related to cardiac devices.
  • Exploration of emerging innovations in the field.

Main Results:

  • Established specialist cardiology cover and arrhythmia pathways are not universally available.
  • Management of arrhythmia remains crucial for general physicians.
  • Key areas include diagnostics, bradycardia pacing, cardiac resynchronisation, and implantable cardioverter defibrillators.

Conclusions:

  • Future innovations include portable diagnostic technologies, antibiotic envelopes, and leadless pacemakers.
  • Continued development in cardiac device technology is essential for improving patient outcomes.
  • Effective management of cardiac arrhythmias requires ongoing physician education and adherence to guidelines.